Increased Diversity in NIH Clinical Trials
New rules aim to boost diversity in NIH-funded clinical trials, ensuring participants better reflect the U.S. population. This means drugs and treatments will be tested on a wider range of people, potentially leading to safer and more effective solutions for everyone. The act also introduces conveniences for trial participants, like flexible follow-up visits, and public awareness campaigns.
Key points
NIH-funded clinical trials must now include clear goals for participant diversity across race, ethnicity, age, and sex.
Trial sponsors will need to submit detailed plans for recruiting and retaining diverse participants, and analyze data for different demographic groups.
The act requires offering less burdensome follow-up options for participants, such as phone, online, or home visits.
NIH will launch a public awareness campaign to highlight the need for diverse clinical trials and encourage participation.
Grants will be available for non-profit organizations to support outreach and education efforts to diversify trial participants.
Expired
Citizen Poll